DGX
Quest Diagnostics, Inc.
NYSE · Healthcare · Medical - Diagnostics & Research · US
$233.87
−0.69%Price chart
Aug 10Aug 13Aug 18Aug 21Aug 26Aug 31Sep 3Sep 9
ValuationView details →
P/E (Fwd)
20.4x
EV/EBITDA
15.9x
Market Cap
$25.81B
MomentumView details →
1D Return
−0.69%
YTD Return
+36.45%
RSI (14)
51.0
ValuationView details →
P/E (Fwd)
20.4x
EV/EBITDA
15.9x
Market Cap
$25.81B
RSI (14)
51.0
MomentumView details →
1D Return
−0.69%
YTD Return
+36.45%
SummaryUpdated Jun 1, 2026
Quest Diagnostics Incorporated (NYSE:DGX) is one of the largest clinical laboratory testing companies in the United States, founded in 1967 and headquartered in Secaucus, New Jersey. The company went public in 1996 and has grown through both organic expansion and strategic acquisitions to become a dominant player in the diagnostic testing industry. Quest operates a nationwide network of laboratories and patient service centers, providing essential diagnostic information services to healthcare providers, patients, and other stakeholders across the healthcare ecosystem.
Similar companies
Latest newsMore news →
Humanity Health Inc. launched its Humanity Biological Age analysis in the United States through Quest Diagnostics' consumer-initiated testing platform questhealth.com.15d agoWhoop announced that its Advanced Labs health screenings no longer require a subscription, and added the multi-cancer early detection test Galleri to its portfolio.22d ago